JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walker, E. S.
Right arrow Articles by Sarubbi, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walker, E. S.
Right arrow Articles by Sarubbi, F. A.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2004, p. 2792-2795, Vol. 42, No. 6
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.6.2792-2795.2004

A Decline in Mupirocin Resistance in Methicillin-Resistant Staphylococcus aureus Accompanied Administrative Control of Prescriptions

Elaine S. Walker,1,2* Foster Levy,3 Mahmoud Shorman,1,2 Gerard David,1,2 Jehad Abdalla,1,2 and Felix A. Sarubbi1,2

James H. Quillen Veterans Affairs Medical Center, Mountain Home, Tennessee 37684,1 Department of Internal MedicineJames H. Quillen College of Medicine,2 Department of Biological Sciences, East Tennessee State University, Johnson City, Tennessee 376143

Received 6 January 2004/ Returned for modification 25 February 2004/ Accepted 7 March 2004

Susceptibility to mupirocin was assessed in methicillin-resistant Staphylococcus aureus isolates selected from eras corresponding to differences in usage rate and prescription policies at a Veterans Affairs medical center. The eras studied encompassed from the time of introduction of the drug to its widespread use, through recommended judicious use, and finally to subsequent stringent administrative control. Prescriptions declined from 3.0 to 0.1 per 1,000 patient days. Precipitous declines first in the numbers of isolates with high-level resistance (from 31% to 4%) and then in those with low-level resistance (from 26% to 10%) accompanied prescription control.


* Corresponding author. Mailing address: James H. Quillen VAMC (11C), Mountain Home, TN 37684. Phone: (423) 439-8089. Fax: (423) 439-6387. E-mail: walkeres{at}etsu.edu.


Journal of Clinical Microbiology, June 2004, p. 2792-2795, Vol. 42, No. 6
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.6.2792-2795.2004




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.